Your browser doesn't support javascript.
loading
Molecular interactions of PCSK9 with an inhibitory nanobody, CAP1 and HLA-C: Functional regulation of LDLR levels.
Fruchart Gaillard, Carole; Ouadda, Ali Ben Djoudi; Ciccone, Lidia; Girard, Emmanuelle; Mikaeeli, Sepideh; Evagelidis, Alexandra; Le Dévéhat, Maïlys; Susan-Resiga, Delia; Lajeunesse, Evelyne Cassar; Nozach, Hervé; Ramos, Oscar Henrique Pereira; Thureau, Aurélien; Legrand, Pierre; Prat, Annik; Dive, Vincent; Seidah, Nabil G.
Afiliación
  • Fruchart Gaillard C; Université Paris-Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SIMoS, 91191 Gif-sur-Yvette, France.
  • Ouadda ABD; Montreal Clinical Research Institute (IRCM), affiliated to the University of Montreal, Laboratory of Biochemical Neuroendocrinology, Montreal, Quebec H2W 1R7, Canada.
  • Ciccone L; Synchrotron SOLEIL, HelioBio group, l'Orme des Merisiers, 91190 Saint-Aubin, France; Department of Pharmacy, University of Pisa, Via Bonanno, 6, 56126 Pisa, Italy.
  • Girard E; Montreal Clinical Research Institute (IRCM), affiliated to the University of Montreal, Laboratory of Biochemical Neuroendocrinology, Montreal, Quebec H2W 1R7, Canada.
  • Mikaeeli S; Montreal Clinical Research Institute (IRCM), affiliated to the University of Montreal, Laboratory of Biochemical Neuroendocrinology, Montreal, Quebec H2W 1R7, Canada.
  • Evagelidis A; Montreal Clinical Research Institute (IRCM), affiliated to the University of Montreal, Laboratory of Biochemical Neuroendocrinology, Montreal, Quebec H2W 1R7, Canada.
  • Le Dévéhat M; Montreal Clinical Research Institute (IRCM), affiliated to the University of Montreal, Laboratory of Biochemical Neuroendocrinology, Montreal, Quebec H2W 1R7, Canada.
  • Susan-Resiga D; Montreal Clinical Research Institute (IRCM), affiliated to the University of Montreal, Laboratory of Biochemical Neuroendocrinology, Montreal, Quebec H2W 1R7, Canada.
  • Lajeunesse EC; Université Paris-Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SIMoS, 91191 Gif-sur-Yvette, France.
  • Nozach H; Université Paris-Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SIMoS, 91191 Gif-sur-Yvette, France.
  • Ramos OHP; Université Paris-Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SIMoS, 91191 Gif-sur-Yvette, France.
  • Thureau A; Synchrotron SOLEIL, HelioBio group, l'Orme des Merisiers, 91190 Saint-Aubin, France.
  • Legrand P; Synchrotron SOLEIL, HelioBio group, l'Orme des Merisiers, 91190 Saint-Aubin, France.
  • Prat A; Montreal Clinical Research Institute (IRCM), affiliated to the University of Montreal, Laboratory of Biochemical Neuroendocrinology, Montreal, Quebec H2W 1R7, Canada.
  • Dive V; Université Paris-Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SIMoS, 91191 Gif-sur-Yvette, France.
  • Seidah NG; Montreal Clinical Research Institute (IRCM), affiliated to the University of Montreal, Laboratory of Biochemical Neuroendocrinology, Montreal, Quebec H2W 1R7, Canada. Electronic address: seidahn@ircm.qc.ca.
Mol Metab ; 67: 101662, 2023 01.
Article en En | MEDLINE | ID: mdl-36566984

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antígenos HLA-C / Proproteína Convertasa 9 Tipo de estudio: Prognostic_studies Idioma: En Revista: Mol Metab Año: 2023 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antígenos HLA-C / Proproteína Convertasa 9 Tipo de estudio: Prognostic_studies Idioma: En Revista: Mol Metab Año: 2023 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Alemania